To determine the prevalence of congenital heart defects (CHDs) in a large, unselected cohort of monochorionic (MC) twins. STUDY DESIGN: We completed a chart review of all MC twin pregnancies in the Kaiser Permanente Northern California population from 1996 to 2003. CHDs were identified by diagnostic codes and confirmed by postnatal echocardiograms. Follow-up was obtained through one year of age. RESULT: A total of 926 liveborn MC twins met inclusion criteria. The prevalence of CHDs was 7.5%, 11.6 times the general population rate (CI 9.2 to 14.5). Septal defects were most common. 20% of infants with heart defects had twin-to-twin transfusion syndrome (TTTS) versus 8% of infants without defects (Po0.01); this association remained significant when controlling for potential confounders. CONCLUSION: The prevalence of CHDs in this large cohort of MC twins was significantly higher than the general population rate, with TTTS an added risk factor.
INTRODUCTION
The incidence of monozygotic twinning, the spontaneous division of a single embryo into two embryos, is reported to be 4 in 1000 livebirths. In pregnancies initiated by assisted reproductive technologies, the incidence can be 6 to 10 times higher. 1 Large studies have shown an increased rate of congenital malformations in twins, particularly monochorionic (MC) twins. 2 In an observational study in 1960, McKeown and Record first presented the idea that same-sex twins may have an increased risk for congenital heart defects (CHDs) in particular. 3 Several more recent studies have affirmed this finding in MC twins. [4] [5] [6] [7] [8] Although the baseline rate of CHDs in singletons is 0.3 to 0.8%, 9, 10 the prevalence in MC twins has been reported to be 3.7 to 11.2%. [4] [5] [6] [7] A 2007 systematic review, including a total of 844 MC twins from four cohort studies, reported an overall prevalence of CHDs of 5.3%, with the most common defect being a ventricular septal defect. 8 Twin-to-twin transfusion syndrome (TTTS), a complication unique to MC twins, appears to be an added risk factor for the development of CHDs. The prevalence of heart defects in TTTS infants have been shown to be nearly twice that of non-TTTS MC twins, 8.0% as compared with 4.2%. 8 Recent cohort studies evaluating the prevalence of heart defects in MC twins have all been performed in tertiary academic centers. [4] [5] [6] [7] This raises the possibility that the reported prevalence in these studies may be increased owing to ascertainment or referral bias. Overall, in a review of recent cohort studies, the prevalence of TTTS was 29.6%, almost double the reported baseline population rate of 15%, further raising concern for such bias. 8 Lastly, like all studies assessing for uncommon outcomes, these studies are somewhat limited by sample size.
Kaiser Permanente Northern California (KPNC) is a large, integrated health care organization that provides care for more than 3.2 million residents, including over 30% of the population of Northern California, through a large network of both rural and urban hospitals. The patient population includes B35 000 pregnant women per year. Except for the lowest and highest income earners, the KPNC membership is representative of the total population in the region. The objective of our study was to determine the prevalence of CHDs in a large, unselected cohort of MC twins in the KPNC system, and to compare this with published rates from tertiary referral centers and with the background population rate. We also sought to investigate the rate of CHDs in uncomplicated MC twins as compared with those with TTTS.
METHODS
We performed a retrospective cohort study of all MC twin pregnancies in the KPNC population delivered between 1996 and 2003. During the timeframe of this study, all twin placentas were submitted for pathologic examination to a single laboratory at Kaiser Permanente Medical Center in Oakland, California. Pathological examination included determination of chorionicity as well as injection studies to identify anastomoses. For the purpose of this study, MC twin pregnancies were identified by a search of the pathology database. Within the KPNC system, a small subset of patients is referred for specialized care to outside, tertiary centers, this includes some cases of prenatally-diagnosed fetal anomalies. To assure inclusion of any such pregnancies within this time period in our study, a separate search of the KPNC referral database, which includes all Kaiser patients referred for evaluation at non-Kaiser hospitals, was performed and MC twin pregnancies were identified and included in the study population.
Pregnancies were excluded from the analysis if spontaneous delivery or termination occurred at less than 24 weeks gestation, both fetuses were stillborn, or insufficient medical records were available (Figure 1) . The deliveries or terminations at less than 24 weeks gestation and stillborn fetuses were excluded as complete autopsy data were not available, and it was therefore not possible to establish confirmed diagnoses of CHDs. To assure complete ascertainment of the outcomes of interest, as well as avoid including infants with transient and self-resolving minor cardiac issues, pregnancies with liveborn infants were only included if the infants received follow-up through Kaiser Permanente until 1 year of age or until death if that occurred before 1 year of age (Figure 1) . Thus, all infants with neonatal demise at less than 1 year were included if they received followup through the time of death.
The primary outcome variable studied was the presence of a CHD diagnosed within the first year of life. Prenatal diagnoses were not assessed in this study. To be included, the defect needed to be confirmed by postnatal echocardiogram and needed to be persistent for the first year of life. The diagnosis of a patent ductus arteriosus was not considered an independent structural CHD in our study. The medical records of all the newborns were searched using both inpatient and outpatient diagnostic codes for all diagnoses of CHDs. The detailed medical records of infants with CHDs identified by diagnostic codes were then individually reviewed to verify these diagnoses with postnatal echocardiograms, and to verify the persistence of these defects through the first year of life. The group with CHDs and the group without, were assessed for the frequency of associated anomalies and of genetic disorders associated with an increased risk for CHDs.
The secondary variable was the diagnosis of TTTS. Both maternal and infant records were searched for diagnostic codes associated with TTTS. In addition, ultrasound reports for all of the identified cases were then individually reviewed to confirm a diagnosis by the polyhydramnios/ oligohydramnios sequence. 11 The prevalence of CHDs in the KPNC MC twin population was compared with that reported in the general infant population. The baseline population prevalence used for comparison was derived from two studies. The first study was the Baltimore-Washington infant study, a 1981 to 1982 population survey that showed a rate of confirmed CHDs up to 1 year of life of 0.4% (664/179 697 infants). 10 The second study of an English health region from 1985 to 2004, revealed a prevalence of CHDs of 0.6% (4444/ 690 215 infants). 12 These studies were selected from the literature given their large study populations and appropriate identification of CHD diagnoses.
All statistical analyses were performed using SAS software version 9.13 (SAS institute, Cary, NC, USA), and a two-sided p value of less than 0.05 was considered significant. Descriptive analysis included frequencies and means. All bivariate analyses of categorical variables were conducted using either Chi-square or Fisher Exact tests. Continuous variables were analyzed using the t-test or the Wilcoxon non-parametric test. A logistic regression analysis was performed to assess the relationship of predictor variables to the diagnosis of CHD after adjusting for gender, gestational age and other associated variables. Before study initiation, approval by the KPNC Institutional Review Board was obtained.
RESULTS
The twin database including all KPNC MC pregnancies from 1996 to 2003 was comprised of 641 pregnancies. Five additional MC twin pregnancies were identified as having delivered at non-Kaiser hospitals, and these were added to the Kaiser Permanente pathology database described above, for a final total of 646 pregnancies. A total of 65 pregnancies were excluded from the analysis, the majority for delivery or termination at less than 24 weeks gestation or because both fetuses were stillborn ( Figure 1) . A total of 926 liveborn infants from 482 pregnancies met followup criteria for inclusion. Of these 482 pregnancies, 5.4% (26/482) resulted in one liveborn and one stillborn twin with the stillborn twin excluded from the analysis. Of the MC twin pregnancies included in the final analysis sample, 3.5% (17/482) were part of a triplet pregnancy, however, only the MC twin set was included in the study and not the third infant.
There were no significant differences in demographic variables for the mothers with pregnancies affected by CHDs as compared with those not affected ( Table 1) . The groups were similar in terms of maternal age, race and diagnoses of pregestational and gestational diabetes.
The prevalence of CHDs in liveborn MC twins in our cohort was 7.5% (Table 2) , as diagnosed by postnatal echocardiogram. This rate was significantly higher than the rate in the general-infant population, as reflected by the Wren et al population cohort. Using the Wren et al. population prevalence of 0.64% for comparison, MC twins are 11.6 times more likely to be born with a CHD than infants in the general population (RR 11.6; CI 9.2-14.5).
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Of the 58 affected pregnancies in our cohort, a single liveborn infant was affected in 47 pregnancies and both liveborns were affected in 11 pregnancies for a total of 69 affected infants. Table 3 illustrates the frequency of specific CHDs. The most common defects were persistent ventricular septal defects and atrial septal defects, affecting 3.8 and 2.1% of all MC infants, respectively. Of the 69 infants with CHDs, 9 infants (13.0%) required surgical intervention to correct the defect. In addition, two infants that died would have ultimately required surgical intervention for survival. One infant was not a surgical candidate secondary to complications of prematurity and so care was withdrawn, and a second infant had a sudden death secondary to aortic stenosis at 2 months of age. Thus, 11 infants had significant cardiac disease at less than 1 year of life, requiring surgical intervention or resulting in death, representing 1.2% of our MC twin cohort. Table 3 also illustrates the proportion of infants with each defect that required surgical correction. The rate of severe CHDs requiring surgery in our MC twin population is 1.8 times higher than the overall population rate of any CHD (RR 1.83, CI 1.1 to 3.30) and 12.1 times higher than the population rate of life-threatening defects (12.1, CI 6.7 to 21.9). 12 Overall, TTTS affected 10.0% (48/482) of pregnancies in this study. Infants with CHDs were significantly more likely to have been affected by TTTS as compared with infants without a CHD (Table 4 ). In MC pregnancies affected by TTTS, there is almost a threefold-increased risk of at least one of the infants being born with a CHD (OR 2.8, CI 1.4 to 5.8), as compared with uncomplicated MC twin pregnancies. This association remained significant after controlling for gestational age at birth, birth weight and gender.
In bivariate analysis, in addition to this association with increased rates of TTTS, infants with a CHD were also born at significantly earlier gestational ages, had lower birth weights, and were more likely to be born with a concomitant patent ductus arteriosus as compared with unaffected infants (Table 4) . In logistic regression analysis with these variables, both the diagnoses of patent ductus arteriosus and lower birth weight remained significantly associated with a higher rate of neonatal CHDs (data not presented). There was no significant difference in the gender distribution or in death at less than 1 year of age between the group affected by CHDs and the unaffected group (Table 4 ). The number of infants with the studied genetic disorders or associated anomalies was not high enough to evaluate statistically. In the entire twin cohort, two infants had trisomy 21 and one infant had trisomy 13. Only one of the two trisomy 21 twins had a complex CHD. The trisomy 13 infant did not have a CHD and its twin was stillborn. There were no cases of DiGeorge syndrome, Noonan syndrome or Turner syndrome. Of the 926 infants, none had abdominal wall defects, three had neural tube defects and two had orofacial clefts. Abbreviation: TTTS, twin-to-twin transfusion syndrome. Table 3 . Frequency of specific congenital heart defects in all monochorionic twins.
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Congenital heart defect present (n ¼ 69) Congenital heart defect absent (n ¼ 857) P Congenital heart defects in monochorionic twins KE Pettit et al DISCUSSION This cohort study, the largest to date, confirms the association of MC twinning with CHDs. The prevalence of CHDs in this unselected cohort of MC twins was actually somewhat higher than previously published rates for MC twins. [4] [5] [6] [7] The CHD diagnoses in our study were all verified postnatally and it was required that they remained persistent during the infant's first year of life; thus, our prevalence rate does not include any transient and self-resolving cardiac abnormalities.
In this study, MC twins with CHDs had lower birth weights than unaffected MC twins, even when controlling for gestational age, and were more likely to have been diagnosed with TTTS. Other studies have also found that infants with CHDs are more likely to be small for gestational age, 13 and have similarly reported the rate of CHDs to be particularly increased in MC twins with TTTS. 8 The mechanisms behind the increase in risk of CHDs in MC twins are the topic of much discussion and debate. Theories proposed include the unequal allocation of progenitor cells to the twins during the twinning process, unequal sharing of the placental parenchyma and aberrant angiogenic factors such as vascular endothelial growth factor. [14] [15] [16] [17] In the setting of TTTS, acquired cardiac lesions due to flow abnormalities are also well documented, as is an increased risk for pulmonary atresia in recipient fetuses. 18 Whether TTTS independently contributes to the development of cardiac defects or if in fact, the physiological shifts caused by the defects instead lead to TTTS, is unknown.
The outcomes of CHDs are quite variable, and include benign lesions that may resolve spontaneously, as well as more serious and life-threatening defects. The majority of the CHDs identified in this study did not require surgical correction and appear to be clinically benign. However, in this cohort, 1.2% of MC infants had significant cardiac disease requiring surgery or resulting in death; this is significantly higher than the population prevalence of all CHDs, substantiating the inherent risk of monochorionicity.
A strength of this study, in addition to the large sample size, is that these cases were drawn from a representative segment of the California population, rather than from a tertiary referral population, making these findings more generalizable. Previous demographic studies have shown the KPNC population to be an excellent representative sample of the Northern California population at large. 19 A further strength is that all CHD diagnoses were verified by neonatal echocardiogram and that follow-up through 1 year of age was available, assuring likely capture of all clinically significant lesions. Previous studies have often utilized only antenatal diagnoses without confirmation by neonatal echocardiograms or pediatric follow-up care. In addition, chorionicity was confirmed by pathologic placental evaluation assuring accurate diagnosis of placentation.
Limitations of this study are those inherent in retrospective studies. There is also the possibility of ascertainment bias of the CHD diagnoses. Infants that deliver preterm, as do many twins, have closer monitoring and may have clinically minor CHDs diagnosed that would have been missed, and resolved spontaneously during childhood, in term infants. Our requirement for persistence of the lesion for 1 year should decrease this potential for such an ascertainment bias. Another limitation is the absence of data on the presence of CHDs in the previable demises, terminations and stillborn infants secondary to incomplete availability of autopsy data. However, this would likely have only further elevated the prevalence we have reported if these fetuses were predisposed to intrauterine demise secondary to a cardiac lesion or were electively terminated owing to prenatal diagnosis of a CHD. Lastly, the general population rate of comparison was extracted from observational studies, 10, 12 rather than using a control group within the KPNC population. However, these were large, thoughtfully conducted population based studies, and have been consistently cited as the most accurate recent representation of the population rate of CHDs. In summary, in this large unselected cohort, MC twinning was a significant risk factor for CHDs. This was particularly evident in twins with TTTS, but is also seen in MC pregnancies without a TTTS diagnosis. These data support the recent recommendations of the American Institute of Ultrasound in Medicine that MC twin pregnancy should be considered an independent indication for fetal echocardiography. 20 Prenatal detection of CHDs in this population could allow for discussions with parents regarding fetal and neonatal prognoses, and may affect pregnancy choices and delivery planning. While many of these cardiac lesions are clinically mild, there does appear to be an elevated risk of severe cardiac disease beyond the background population rate. Whether this results from monozygosity, and would also be present in monozygotic dichorionic pregnancies or is a complication unique to MC placentation, is an important subject of future investigation.
